Overview

Remimazolam Phase II Cardiac Anesthesia Study

Status:
Completed

Trial end date:
2014-02-19

Target enrollment:

Participant gender:

Summary

This phase II study in patients undergoing elective cardiac surgery will evaluate the efficacy, safety, and pharmacokinetics of remimazolam, compared with propofol and sevoflurane, during the induction and maintenance of general anesthesia.

Phase:

Phase 2

Details

Lead Sponsor:

Paion UK Ltd.

Collaborator:

Aptiv Solutions

Treatments:

Fentanyl
Propofol
Remifentanil
Rocuronium
Sevoflurane